CHA2S2-VASc Risk

1 year risk of TE event in a non-anticoagulated patient with non-valvular AF

CHF+1
Hypertension+1
Age<65+0
65-74+1
>74+2
Diabetes Mellitus+1
Stroke / TIA / TE+2
Vascular Disease+1
SexMale+0
SexFemale+1
Stroke risk at 1 year
01.9%1.2-3.0%
12.8%2.0-3.8%
24.0%3.1-5.1%
35.9%4.6-7.3%
48.5%6.3-11.1%
512.5%8.2-17.5%
618.2%10.5-27%

Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. The Birmingham 2009 schema.
Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation.
Chest. 2010 Feb;137(2):263-72.

Lip, GY; Lane, DA (19 May 2015).
Stroke prevention in atrial fibrillation: a systematic review.
JAMA 313 (19): 1950–62.

http://sparctool.com/

http://www.acc.org/tools-and-practice-support/clinical-toolkits/atrial-fibrillation-afib

https://en.wikipedia.org/wiki/CHA2DS2%E2%80%93VASc_score

Richard Pearson 2015